Skip to main content

Table 1 Main effects and interaction P values for drug and time analyzed by two-way ANOVA in Experiment I

From: Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome

Parameters (figure number)

P time

P drug

P interaction

Body weight (Fig. 1a)

<0.01

NS

NS

24 h-food intake (Fig. 1b)

<0.01

NS

<0.01

24 h-water intake (Fig. 1c)

<0.01

<0.01

<0.01

24 h-urine volume (Fig. 1d)

<0.01

<0.01

<0.01

24 h-UGE (Fig. 1e)

<0.01

<0.01

<0.01

24 h-urinary sodium excretion (Fig. 1f)

<0.01

<0.01

<0.01

24 h-sodium balance (Fig. 2a)

<0.01

<0.01

<0.01

Cumulative 24 h-sodium balance (Fig. 2b)

<0.01

<0.01

<0.01

24 h-water balance (Fig. 2c)

<0.01

<0.05

0.6951

Cumulative 24 h-water balance (Fig. 2d)

<0.01

<0.05

<0.01

Body weight (Fig. 3a)

<0.01

<0.05

<0.01

24 h-food intake (Fig. 3b)

<0.01

<0.01

<0.01

24 h-water intake (Fig. 3c)

<0.01

<0.01

<0.01

24 h-urine volume (Fig. 3d)

<0.01

<0.01

<0.01

24 h-UGE (Fig. 3e)

<0.01

<0.01

<0.01

24 h-urinary sodium excretion (Fig. 3f)

<0.01

NS

<0.01

24 h-sodium balance (Fig. 3g)

<0.01

NS

NS

24 h-water balance (Fig. 3h)

<0.01

NS

<0.01

  1. UGE urinary glucose excretion; NS not significant